Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kyorin Pharmaceutical Co. Ltd.

www.kyorin-pharm.co.jp

Latest From Technolas Perfect Vision GMBH

Option-To-Acquire In Medical Device Deals Rarely Gets Exercised

For a device start-up, an option to acquire presents a clear path to liquidity, but there are drawbacks. An analysis of deals in Elsevier’s Strategic Transactions suggests the importance of such options to the overall merger and acquisition ecosystem might be overblown.

Medical Device Deals

News In Brief

GE Healthcare buys U-Systems for breast ultrasound device. Bausch & Lomb snaps up Technolas Perfect Vision. Orthofix settles Blackstone kickbacks case. More news briefs.

Medical Device

Femtosecond Lasers: Expanding The Premium Cataract Surgery Market

When femtosecond lasers for cataract surgery hit the market in early 2011, it was apparent that that they would bring unprecedented precision to the procedure. The key questions surrounding this emerging field quickly shifted to commercial viability: how would US cataract surgeons and facilities be able to pay for this expensive new technology in a procedure that is reimbursed almost entirely by Medicare, and therefore subject to strict billing limitations? A survey of early laser adopters in the US, detailed below, suggests that surgeons are successfully navigating these regulatory hurdles and incorporating the new lasers into their practices.

Medical Device Surgical Procedures

News In Brief

CardioNet buys CardioCore Lab. HeartWare gears for HVAD rollout. Zimmer prevails in Genzyme patent case. CardioDx gains Corus CAD heart test Medicare coverage. More news briefs.

Medical Device
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • Kyorin Pharmaceutical Co. Ltd.
  • Senior Management
  • Mitsutomo Miyashita, PhD, Pres. & CEO
  • Contact Info
  • Kyorin Pharmaceutical Co. Ltd.
    Phone: (81) 3 3525 4711
    Ochyanomizu Sola City 16F
    Kanda Surugadai
    Tokyo, 101-8311
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register